Citation: Au. Buzdar et al., Letrozole in second-line therapy of advanced breast cancer: More questionsthan answers - Reply, J CL ONCOL, 19(23), 2001, pp. 4354-4355
Authors:
Ellis, MJ
Coop, A
Singh, B
Mauriac, L
Llombert-Cussac, A
Janicke, F
Miller, WR
Evans, DB
Dugan, M
Brady, C
Quebe-Fehling, E
Borgs, M
Citation: Mj. Ellis et al., Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: Evidence from a phase III randomized trial, J CL ONCOL, 19(18), 2001, pp. 3808-3816
Authors:
Buzdar, A
Douma, J
Davidson, N
Elledge, R
Morgan, M
Smith, R
Porter, L
Nabholtz, J
Xiang, X
Brady, C
Citation: A. Buzdar et al., Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate, J CL ONCOL, 19(14), 2001, pp. 3357-3366
Authors:
van Adelsberg, J
Sehgal, S
Kukes, A
Brady, C
Barasch, J
Yang, J
Huan, YH
Citation: J. Van Adelsberg et al., Activation of hepatocyte growth factor (HGF) by endogenous HGF activator is required for metanephric kidney morphogenesis in vitro, J BIOL CHEM, 276(18), 2001, pp. 15099-15106
Authors:
Schenker, S
Stein, PC
Wolny, JA
Brady, C
McGarvey, JJ
Toftlund, H
Hauser, A
Citation: S. Schenker et al., Biphasic behavior of the high-spin -> low-spin relaxation of [Fe(btpa)](PF6)(2) in solution (btpa = N,N,N ',N '-tetrakis(2-pyridylmethyl)-6,6 '-bis(aminomethyl)-2,2 '-bipyridine), INORG CHEM, 40(1), 2001, pp. 134-139
Citation: K. Stukenberg et al., Use of the MMPI-2's VRIN scale with severely disturbed populations: Consistent responding may be more problematic than inconsistent responding, PSYCHOL REP, 86(1), 2000, pp. 3-14
Authors:
Bennett, MW
O'Connell, J
Roche, D
Brady, C
Kelly, J
Collins, JK
Shanahan, F
Citation: Mw. Bennett et al., Gastric cancer cell lines lack Fas ligand (FasL) expression but kill T cells via a FasL independent pathway - Reply, GUT, 46(5), 2000, pp. 739-740
Authors:
Bennett, MW
O'Connell, J
O'Sullivan, GC
Roche, D
Brady, C
Collins, JK
Shanahan, F
Citation: Mw. Bennett et al., Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium: a potential mechanism of apoptotic epithelial turnover, DIS ESOPHAG, 12(2), 1999, pp. 90-98
Citation: C. Brady et L. Reavill, Football, business, and government - Can studies of high-level teams across disciplines produce generic principles for systems and management?, SYST PR ACT, 12(5), 1999, pp. 533-553
Authors:
Fisher, R
Lilie, S
Evans, C
Hollon, G
Sands, M
DePaul, D
Brady, C
Lindbom, D
Judd, D
Miller, M
Hultgren, T
Citation: R. Fisher et al., Political ideologies and support for censorship: Is it a question of whoseox is being gored?, J APPL SO P, 29(8), 1999, pp. 1705-1731
Authors:
Bennett, MW
O'Connell, J
O'Sullivan, GC
Roche, D
Brady, C
Kelly, J
Collins, JK
Shanahan, F
Citation: Mw. Bennett et al., Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer, GUT, 44(2), 1999, pp. 156-162